1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. HOOKIPA PHARMA INC
Hookipa Pharma Inc XNAS: HOOK

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Hookipa Pharma Inc is on 09 Sep 2025 for the purpose of HOOKIPA Pharma Inc Annual General Meeting for 2025 See details


Insider Trading disclosures for Hookipa Pharma Inc

The latest disclosure was made by Terry Coelho in Hookipa Pharma Inc where a trade of 13,609 Common Stock done at an average price of $0.9 was reported to US exchanges on July 22, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Terry Coelho Director, EVP and CFO Sale of securities on an exchange or to another person at price $ 0.92 per share. 22 Jul 2025 13,609 56,266 (0%) 0% 0.9 12,520 Common Stock
Malte Peters Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.92 per share. 22 Jul 2025 29,176 79,519 (0%) 0% 0.9 26,842 Common Stock
Terry Coelho Director, EVP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jul 2024 69,875 69,875 (0%) 0% 0 Common Stock
Malte Peters Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jul 2024 108,695 108,695 (0%) 0% 0 Common Stock
Jan G. J. van de Winkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 98,000 98,000 - - Stock Option (Right to Buy)
Julie O'Neill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 49,000 49,000 - - Stock Option (Right to Buy)
Terry Coelho Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 49,000 49,000 - - Stock Option (Right to Buy)
David Ross Kaufman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 49,000 49,000 - - Stock Option (Right to Buy)
Malte Peters Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 49,000 49,000 - - Stock Option (Right to Buy)
Timothy P. Reilly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 49,000 49,000 - - Stock Option (Right to Buy)
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2024 971,400 971,400 - - Stock Option (Right to Buy)
Reinhard Kandera Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2024 406,200 406,200 - - Stock Option (Right to Buy)
Klaus Orlinger Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2024 367,300 367,300 - - Stock Option (Right to Buy)
Roman Necina Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2024 367,300 367,300 - - Stock Option (Right to Buy)
Mark Winderlich Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2024 250,000 250,000 - - Stock Option (Right to Buy)
Mark Winderlich Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2024 50,000 50,000 - - Stock Option (Right to Buy)
Reinhard Kandera Director, Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.72 per share. 21 Aug 2023 7,000 43,092 (0%) 0% 0.7 5,075 Common Stock
Reinhard Kandera Director, Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.71 per share. 16 Aug 2023 8,000 36,092 (0%) 0% 0.7 5,712 Common Stock
Joern Aldag Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.83 per share. 07 Jul 2023 5,000 71,952 (0%) 0% 0.8 4,142 Common Stock
Joern Aldag Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.81 per share. 07 Jul 2023 5,000 66,952 (0%) 0% 0.8 4,050 Common Stock
Joern Aldag Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.89 per share. 05 Jul 2023 5,000 61,952 (0%) 0% 0.9 4,450 Common Stock
Joern Aldag Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.89 per share. 03 Jul 2023 5,000 56,952 (0%) 0% 0.9 4,456 Common Stock
Reinhard Kandera Director, Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.88 per share. 30 Jun 2023 12,000 28,092 (0%) 0% 0.9 10,560 Common Stock
Jan G. J. van de Winkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 52,000 52,000 - - Stock Option (Right to Buy)
Julie O'Neill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 26,000 26,000 - - Stock Option (Right to Buy)
Mary Theresa Coelho Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 52,000 52,000 - - Stock Option (Right to Buy)
David Ross Kaufman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 26,000 26,000 - - Stock Option (Right to Buy)
Malte Peters Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 52,000 52,000 - - Stock Option (Right to Buy)
Timothy P. Reilly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 26,000 26,000 - - Stock Option (Right to Buy)
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 513,600 513,600 - - Stock Option (Right to Buy)
Reinhard Kandera Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 214,800 214,800 - - Stock Option (Right to Buy)
Klaus Orlinger Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 194,200 194,200 - - Stock Option (Right to Buy)
Roman Necina Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 112,100 112,100 - - Stock Option (Right to Buy)
Christine D. Baker Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 275,800 275,800 - - Stock Option (Right to Buy)
Katia Schlienger Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 184,000 184,000 - - Stock Option (Right to Buy)
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 275,250 275,250 - - Stock Option (Right to Buy)
Reinhard Kandera Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 92,950 92,950 - - Stock Option (Right to Buy)
Jan G. J. van de Winkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 92,950 92,950 - - Stock Option (Right to Buy)
David Ross Kaufman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 20,000 20,000 - - Stock Option (Right to Buy)
Roman Necina Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 48,350 48,350 - - Stock Option (Right to Buy)
Christine D. Baker Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2022 275,250 275,250 - - Stock Option (Right to Buy)
Reinhard Kandera Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2022 92,950 92,950 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2022 92,950 92,950 - - Stock Option (Right to Buy)
Klaus Orlinger Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2022 48,350 48,350 - - Stock Option (Right to Buy)
Roman Necina Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2022 48,350 48,350 - - Stock Option (Right to Buy)
Christine D. Baker Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2022 100,000 100,000 - - Stock Option (Right to Buy)
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 39,853 39,853 - - Stock Option (Right to Buy)
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 3.00 per share. 01 Feb 2022 47,824 51,952 (0%) 0% 3 143,472 Common Stock
Reinhard Kandera Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.00 per share. 01 Feb 2022 14,056 16,092 (0%) 0% 3 42,168 Common Stock
Reinhard Kandera Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 23,427 23,427 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 24,888 24,888 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Grant, award, or other acquisition of securities at price $ 3.00 per share. 01 Feb 2022 14,933 100,240 (0%) 0% 3 44,799 Common Stock
Klaus Orlinger Executive VP, Research Grant, award, or other acquisition of securities at price $ 3.00 per share. 01 Feb 2022 9,188 10,404 (0%) 0% 3 27,564 Common Stock
Klaus Orlinger Executive VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 12,654 12,654 - - Stock Option (Right to Buy)
Roman Necina Chief Technology Officer Grant, award, or other acquisition of securities at price $ 3.00 per share. 01 Feb 2022 12,892 14,876 (0%) 0% 3 38,676 Common Stock
Roman Necina Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 21,486 21,486 - - Stock Option (Right to Buy)
Christine D. Baker Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 22,763 22,763 - - Stock Option (Right to Buy)
Christine D. Baker Chief Business Officer Grant, award, or other acquisition of securities at price $ 3.00 per share. 01 Feb 2022 13,658 16,158 (0%) 0% 3 40,974 Common Stock
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2021 207,600 207,600 - - Stock Option (Right to Buy)
Reinhard Kandera Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2021 69,300 69,300 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2021 95,250 95,250 - - Stock Option (Right to Buy)
Klaus Orlinger Sr. VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2021 26,050 26,050 - - Stock Option (Right to Buy)
Roman Necina Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2021 36,750 36,750 - - Stock Option (Right to Buy)
Christine D. Baker Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2021 49,950 49,950 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 16 Dec 2020 640 56,774 (0%) 0% 0.1 64 Common Stock
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2020 5,965 7,669 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2020 11,367 14,208 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2020 31,656 8,079 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2020 640 39,735 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Sale of securities on an exchange or to another person at price $ 11.76 per share. 16 Dec 2020 16,478 77,403 (0%) 0% 11.8 193,781 Common Stock
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 16 Dec 2020 29,628 93,881 (0%) 0% 0.1 2,963 Common Stock
Igor Matushansky Chief Medical Officer Sale of securities on an exchange or to another person at price $ 11.70 per share. 16 Dec 2020 11,501 64,253 (0%) 0% 11.7 134,562 Common Stock
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 16 Dec 2020 19,360 75,754 (0%) 0% 0.1 1,936 Common Stock
Igor Matushansky Chief Medical Officer Sale of securities on an exchange or to another person at price $ 11.70 per share. 16 Dec 2020 380 56,394 (0%) 0% 11.7 4,446 Common Stock
Jean-Charles Soria Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2020 19,200 19,200 - - Stock Option (Right to Buy)
Michael A. Kelly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2020 5,754 5,754 (0%) 0% 0 Common Stock
Sander van Deventer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2020 2,485 2,485 (0%) 0% 0 Common Stock
Graziano Seghezzi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2020 4,708 4,708 (0%) 0% 0 Common Stock
Jan G. J. van de Winkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2020 9,153 9,153 (0%) 0% 0 Common Stock
Julie O'Neill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2020 4,969 4,969 (0%) 0% 0 Common Stock
Christoph Lengauer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2020 4,603 4,603 (0%) 0% 0 Common Stock
David Ross Kaufman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2020 4,577 4,577 (0%) 0% 0 Common Stock
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2020 4,128 4,128 (0%) 0% 0 Common Stock
Reinhard Kandera Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2020 2,036 2,036 (0%) 0% 0 Common Stock
Igor Matushansky Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2020 2,736 56,134 (0%) 0% 0 Common Stock
Klaus Orlinger EVP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2020 1,216 1,216 (0%) 0% 0 Common Stock
Roman Necina Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2020 1,984 1,984 (0%) 0% 0 Common Stock
Michael A. Kelly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 9,600 9,600 - - Stock Option (Right to Buy)
Sander van Deventer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 9,600 9,600 - - Stock Option (Right to Buy)
Graziano Seghezzi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 9,600 9,600 - - Stock Option (Right to Buy)
Jan G. J. van de Winkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 19,200 19,200 - - Stock Option (Right to Buy)
Julie O'Neill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 9,600 9,600 - - Stock Option (Right to Buy)
Christoph Lengauer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 9,600 9,600 - - Stock Option (Right to Buy)
David Ross Kaufman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 9,600 9,600 - - Stock Option (Right to Buy)
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Apr 2020 200,000 0 - - Stock Option (Right to Buy)
Reinhard Kandera Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Apr 2020 77,400 0 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Apr 2020 65,200 0 - - Stock Option (Right to Buy)
Klaus Orlinger EVP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Apr 2020 30,000 0 - - Stock Option (Right to Buy)
Roman Necina Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Apr 2020 50,000 0 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Sale of securities on an exchange or to another person at price $ 12.73 per share. 29 Jan 2020 5,500 53,398 (0%) 0% 12.7 69,992 Common Stock
Anders Lilja Sr. VP, Technical Development Sale of securities on an exchange or to another person at price $ 12.17 per share. 23 Jan 2020 4,075 0 (0%) 0% 12.2 49,601 Common Stock
Anders Lilja Sr. VP, Technical Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jan 2020 7,568 13,098 - - Stock Option (Right to Buy)
Anders Lilja Sr. VP, Technical Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jan 2020 4,075 0 - - Stock Option (Right to Buy)
Anders Lilja Sr. VP, Technical Development Sale of securities on an exchange or to another person at price $ 12.81 per share. 23 Jan 2020 7,568 0 (0%) 0% 12.8 96,932 Common Stock
Anders Lilja Sr. VP, Technical Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 23 Jan 2020 7,568 7,568 (0%) 0% 0.1 757 Common Stock
Anders Lilja Sr. VP, Technical Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 23 Jan 2020 4,075 4,075 (0%) 0% 0.1 408 Common Stock
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 16 Jan 2020 571 1,711 (0%) 0% 0.1 57 Common Stock
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2020 6,789 7,741 - - Stock Option (Right to Buy)
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2020 571 14,530 - - Stock Option (Right to Buy)
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2020 1,140 0 - - Stock Option (Right to Buy)
Klaus Orlinger Sr. VP, Research Sale of securities on an exchange or to another person at price $ 12.02 per share. 16 Jan 2020 6,789 0 (0%) 0% 12.0 81,592 Common Stock
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 16 Jan 2020 6,789 6,789 (0%) 0% 0.1 679 Common Stock
Klaus Orlinger Sr. VP, Research Sale of securities on an exchange or to another person at price $ 11.56 per share. 16 Jan 2020 1,711 0 (0%) 0% 11.6 19,781 Common Stock
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 16 Jan 2020 1,140 1,140 (0%) 0% 0.1 114 Common Stock
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 14 Jan 2020 1,142 8,500 (0%) 0% 0.1 114 Common Stock
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jan 2020 1,142 1,140 - - Stock Option (Right to Buy)
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jan 2020 7,358 0 - - Stock Option (Right to Buy)
Klaus Orlinger Sr. VP, Research Sale of securities on an exchange or to another person at price $ 11.30 per share. 14 Jan 2020 8,500 0 (0%) 0% 11.3 96,053 Common Stock
Klaus Orlinger Sr. VP, Research Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 14 Jan 2020 7,358 7,358 (0%) 0% 0.1 736 Common Stock
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 19 Dec 2019 6,000 49,411 (0%) 0% 0.1 600 Common Stock
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2019 19,891 25,575 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2019 6,000 40,375 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Sale of securities on an exchange or to another person at price $ 9.93 per share. 19 Dec 2019 10,404 58,898 (0%) 0% 9.9 103,312 Common Stock
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 19 Dec 2019 19,891 69,302 (0%) 0% 0.1 1,989 Common Stock
Sander van Deventer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 9,600 9,600 - - Stock Option (Right to Buy)
Graziano Seghezzi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 9,600 9,600 - - Stock Option (Right to Buy)
Jan G. J. van de Winkel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 28,800 28,800 - - Stock Option (Right to Buy)
Julie O'Neill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 9,600 9,600 - - Stock Option (Right to Buy)
Christoph Lengauer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2019 9,600 9,600 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. 17 Dec 2019 26,312 54,895 (0%) 0% 0.1 2,631 Common Stock
Igor Matushansky Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2019 26,312 46,375 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Sale of securities on an exchange or to another person at price $ 7.87 per share. 17 Dec 2019 11,484 43,411 (0%) 0% 7.9 90,379 Common Stock
Roman Necina Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2019 125,008 125,008 - - Stock Option (Right to Buy)
Joern Aldag Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 604,656 604,656 - - Stock Option (Right to Buy)
Michael A. Kelly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 19,200 19,200 - - Stock Option (Right to Buy)
Reinhard Kandera Director, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 87,648 87,648 - - Stock Option (Right to Buy)
Sander van Deventer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 19,200 19,200 - - Stock Option (Right to Buy)
Graziano Seghezzi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 19,200 19,200 - - Stock Option (Right to Buy)
Julie O'Neill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 6,924 6,924 - - Stock Option (Right to Buy)
Christoph Lengauer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 6,924 6,924 - - Stock Option (Right to Buy)
Igor Matushansky Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 52,064 52,064 - - Stock Option (Right to Buy)
Anders Lilja Sr. VP, Technical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 42,784 42,784 - - Stock Option (Right to Buy)
Klaus Orlinger Sr. VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 42,784 42,784 - - Stock Option (Right to Buy)
David Ross Kaufman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 19,200 19,200 - - Stock Option (Right to Buy)
David Pinschewer Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2019 116,416 116,416 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters